Medicines For Europe And European Commission Aligned On Energy Rationing
Supply Chain Disruptions Could Affect Biological And Antibiotic Medicines The Most
Medicines for Europe has urged the European Commission to exempt pharmaceutical suppliers, particularly those of biologic and antibiotic medicines, from any perspective energy rationing in the region, in line with new public guidelines.
You may also be interested in...
Pharmaceutical leaders are responding to the many and varied challenges arising from the war in Ukraine.
Medicines for Europe has urged the European Commission to enshrine security of supply considerations for essential medicines into legislature. Without these, additional cost containment measures for off-patent medicines under consideration by member states may ultimately threaten access by making production unsustainable for manufacturers.
Despite a couple of setbacks during Q2, Amneal has sustained continual growth across its business, particularly in the injectables space.